The FDA plans to increase inspections at Indian drug manufacturing units in 2024. They conducted over 200 inspections in 2023. The Indian pharmaceuticals industry needs to implement good manufacturing practices. Government investment in automation, the drug regulatory body, and drug quality monitoring is necessary.